Acute neurological deficits in a young adult with cystic fibrosis

Pediatric Pulmonology

Volumn 35, Issue 2, 2003, Pages 147-151

  Sritippayawan, Suchada ^a   MacLaughlin, Eithne F ^a   Woo, Marlyn S ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Cystic fibrosis; Indwelling intravenous catheters; Paradoxical embolism; Patent foramen ovale; Port A Cath ; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ORAL CONTRACEPTIVE AGENT; VITAMIN K GROUP;

ADULT; ARTICLE; CASE REPORT; CYSTIC FIBROSIS; DEEP VEIN THROMBOSIS; ELECTROENCEPHALOGRAM; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART ATRIUM THROMBOSIS; HUMAN; INDWELLING CATHETER; INSULIN DEPENDENT DIABETES MELLITUS; LUNG FUNCTION TEST; NEUROLOGIC DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; PARADOXICAL EMBOLISM; PARANASAL SINUSITIS; PRIORITY JOURNAL; THROMBOEMBOLISM; THROMBOPHILIA; TRANSTHORACIC ECHOCARDIOGRAPHY; VITAMIN SUPPLEMENTATION;

ADULT; CATHETERS, INDWELLING; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY; EMBOLISM, PARADOXICAL; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 0037318121     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.10198     Document Type: Article

References (20)

1. Pattison J, Heaf DP. Totally implantable vascular access in treatment of cystic fibrosis. Lancet 1986;i:799.
2. Cassey J, Ford WDA, O'Brien L, Martin AJ. Totally implantable system for venous access in children with cystic fibrosis. Clin Pediatr (Phila) 1988;27:91-95.
3. Morris JB, Occhionero ME, Gauderer MWL, Stem RC, Doershuk CF. Totally implantable vascular access devices in cystic fibrosis: a four-year experience with fifty-eight patients. J Pediatr 1990; 117:82-85.
4. Deerojanawong J, Sawyer SM, Fink AM, Stokes KB, Robertson CF. Totally implantable venous access devices in children with cystic fibrosis; incidence and type of complications. Thorax 1998;53:285-289.
5. Yung B, Elborn JS, Campbell IA, Summers Y, Beckles M, Woodcock AA. Thromboembolism related to Port-a-Cath device in a patient with cystic fibrosis. Thorax 1997;52:98-99.
6. Playfor SD, Smyth AR. Paradoxical embolism in a boy with cystic fibrosis and a stroke. Thorax 1999;54:1139-1140.
7. Sola JE, Stone MM, Wise B, Colombani PM. Atypical thrombotic and septic complications of totally implantable venous access devices in patient with cystic fibrosis. Pediatr Pulmonol 1992;14: 239-242.
8. Chaturvedi S. Coagulation abnormalities in adults with cryptogenic stroke and persistent foramen ovale. J Neurol Sci 1998;160: 158-160.
9. Van Koningsbruggen S, Hamm M, Geisen C, Michalk D, Rietschel E, Protein C, protein S, antithrombin III, and APC resistance in CF patients [abstract]. Pediatr Pulmonol [Suppl] 2000;20:344.
10. Loscalzo J. Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J 1986;112: 141-145.
11. Thomas JD, Tobakin BS, Ittleman FP. Atrial septal defect with right to left shunt despite normal pulmonary artery pressure. J Am Coll Cardiol 1987;9:221-224.
12. Lechat PH, Mas JL, Lascault G, Loron PH, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1998;318: 1148-1152.
13. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59: 17-20.
14. Lynch JJ, Schuchard GH, Gross CM, Wann LS. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsava maneuver contrast echocardiography. Am J Cardiol 1984; 53:1478-1480.
15. Penther P. Patent foramen ovale: an anatomical study, Apropos of 500 consecutive autopsies. Arch Mal Coeur 1994;87: 15-21.
16. Weihs W, Schuchkez H, Schwarz G, Fuchs G, Weihs B. Preoperative diagnosis of a patent foramen ovale: rational use of transthoracic and transesophageal contrast echocardiography. Anaesthesist 1998;47:833-837.
17. Nendaz M, Sarasin FP, Bogousslavsky J. How to prevent stroke recurrence in patients with patent foramen ovale: anticoagulants, antiaggregants, foramen closure or nothing? Eur Neurol 1997;37: 199-204.
18. Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low dose of warfarin can prevent thrombosis in central venous catheter. Ann Intern Med 1990;112:423-428.
19. David M, Andrew M. Venous thrombolic complications in children. J Pediatr 1993;123:337-346.
20. Hogan MJ, Coley BD, Shiels WE II, Allen ED, McCoy KS. Recurrent deep venous thrombosis complicating PICC line replacement in two patients with cystic fibrosis and activated protein C-resistance. Pediatr Radiol 1998;28:552-553.